Literature DB >> 18848689

Impact of echocardiography in patients hospitalized for heart failure: a prospective observational study.

Christophe Tribouilloy1, Dan Rusinaru, Haïfa Mahjoub, Thomas Goissen, Franck Lévy, Marcel Peltier.   

Abstract

BACKGROUND: Echocardiography is recommended for all patients with a clinical diagnosis of heart failure (HF). Management of HF in daily practice differs from guidelines. AIM: To evaluate the prognostic impact of echocardiography in patients hospitalized for a first episode of HF.
METHODS: Consecutive patients (n=799) hospitalized for a first episode of HF were prospectively enrolled during 2000. Propensity scores and multivariable analyses were used to reduce the imbalance in baseline covariates between the Echo and No-Echo groups.
RESULTS: During hospitalization, echocardiography was not performed in 151 patients (19%). Patients in the No-Echo group were older, more likely to be female, less frequently admitted to cardiology departments, and had lower rates of life-saving drugs prescribed at discharge. After adjustment for covariates of prognostic importance, use of echocardiography was associated with lower relative risk of three-year overall mortality (hazard ratio [HR] 0.61, 95% confidence interval [CI] 0.48-0.78, p<0.001) and cardiovascular mortality (HR 0.52, 95% CI 0.39-0.70, p<0.001). The three-year relative survival of the Echo group (observed/expected survival) was higher than that of the No-Echo group. Using propensity scores, the performance of echocardiography during hospitalization remained related to reduced three-year overall mortality (HR 0.55, 95% CI 0.39-0.79, p=0.001) and cardiovascular mortality (HR 0.59, 95% CI 0.37-0.95, p=0.03).
CONCLUSION: Echocardiography is still underused in elderly patients with HF. Use of echocardiography appears to be associated with more intensive medical therapy and improved outcome.

Entities:  

Mesh:

Year:  2008        PMID: 18848689     DOI: 10.1016/j.acvd.2008.06.012

Source DB:  PubMed          Journal:  Arch Cardiovasc Dis        ISSN: 1875-2128            Impact factor:   2.340


  7 in total

1.  The role of M-mode echocardiography in patients with heart failure and preserved ejection fraction: A prospective cohort study.

Authors:  Xin Li; Xinwen Min
Journal:  Exp Ther Med       Date:  2020-01-07       Impact factor: 2.447

2.  4 Dimensional XStrain speckle tracking echocardiography: comprehensive evaluation of left ventricular strain and twist parameters in healthy Indian adults during COVID-19 pandemic.

Authors:  Akhil Mehrotra; Shubham Kacker; Mohammad Shadab; Naveen Chandra; Alok Kumar Singh
Journal:  Am J Cardiovasc Dis       Date:  2022-08-15

3.  Association between compliance with quality indicators and hospitalisation expenses in patients with heart failure: a retrospective study using quantile regression model in China.

Authors:  Rong Fu; Shaodan Feng; Yilong Wu; Fei He; Zheng Lin; Yixian Jiang; Zhijian Hu
Journal:  BMJ Open       Date:  2020-07-23       Impact factor: 2.692

Review 4.  Chronic heart failure: we are fighting the battle, but are we winning the war?

Authors:  John J Atherton
Journal:  Scientifica (Cairo)       Date:  2012-12-20

5.  Global longitudinal strain corrected by RR interval is a superior predictor of all-cause mortality in patients with systolic heart failure and atrial fibrillation.

Authors:  Daniel Modin; Morten Sengeløv; Peter Godsk Jørgensen; Niels Eske Bruun; Flemming Javier Olsen; Maria Dons; Thomas Fritz Hansen; Jan Skov Jensen; Tor Biering-Sørensen
Journal:  ESC Heart Fail       Date:  2017-10-11

Review 6.  Echo and heart failure: when do people need an echo, and when do they need natriuretic peptides?

Authors:  Daniel Modin; Ditte Madsen Andersen; Tor Biering-Sørensen
Journal:  Echo Res Pract       Date:  2018-04-24

7.  Comprehensive assessment of left ventricular myocardial function by two-dimensional speckle-tracking echocardiography.

Authors:  Vicente Mora; Ildefonso Roldán; Elena Romero; Diana Romero; Javier Bertolín; Natalia Ugalde; Carmen Pérez-Olivares; Melisa Rodriguez-Israel; Jana Pérez-Gozalbo; Jorge A Lowenstein
Journal:  Cardiovasc Ultrasound       Date:  2018-09-18       Impact factor: 2.062

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.